GSK
GSK Consumer Healthcare announces new Asia Pacific Regional Head
January 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline
GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy
January 4, 2018Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma
NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …
GSK forced to pay back £1.5m to Scottish Government after recent job cuts
December 20, 2017Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma
British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …
Two big pharma companies accused of false marketing
December 6, 2017Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …
GSK commits to multi-million investment in UK life sciences sector deal
December 6, 2017Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …
FDA approves first-ever two-drug HIV regimen, GSK’s Juluca
November 22, 2017Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma
GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
GSK gets EU go-ahead for triple therapy inhaler in COPD
November 16, 2017Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma
The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …
GSK indicates a return to oncology by appointing Roche veteran
November 9, 2017Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical
GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …
GSK’s R&D head to move on after shift in focus
November 3, 2017Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
GSK’s experimental multiple myeloma scores Breakthrough designation with FDA
November 3, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
GSK eyes healthcare expansion, hits targets due to new drugs
October 26, 2017Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical
During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …
Pfizer to begin auction of consumer health division next month
October 26, 2017Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle
Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …
GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost
October 25, 2017Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma
GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
